Oral administration of bone marrow-derived mesenchymal stem cells attenuates intestinal injury in necrotizing enterocolitis

Oral administration of bone marrow-derived mesenchymal stem cells attenuates intestinal injury in necrotizing enterocolitis

Background Necrotizing enterocolitis (NEC) is a major cause of morbidity in premature infants. However, effective treatment options for NEC are currently lacking. Purpose This study aimed to determine the optimal dose of intraperitoneally administered bone marrow-derived mesenchymal stem cells (BM-M...

Full description

Bibliographic Details
Main Authors: Yeong Seok Lee, Yong Hoon Jun, Juyoung Lee
Format: Article
Language:English
Published: The Korean Pediatric Society 2024-03-01
Series:Clinical and Experimental Pediatrics
Subjects:
necrotizing enterocolitis
neonate
mesenchymal stem cells
Online Access:http://www.e-cep.org/upload/pdf/cep-2023-01151.pdf

Internet

http://www.e-cep.org/upload/pdf/cep-2023-01151.pdf

Similar Items